References
- Bedwell A E, Elson C J, Hinton C E. Immunological involvement in the pathogenesis of pristane induced arthritis. Scand J Immunol 1987; 25: 393–398
- Wooley P H, Seibold J R, Whalen J D, Chapdelaine J M. Pristane induced arthritis. The immunologic and genetic features of an experimental murine model of autoimmune disease. Arthritis Rheum 1989; 32: 1022–1030
- Thompson S J, Rook G AW, Brealey R J, van der Zee R, Elson C J. Autoimmune reactions to heat shock proteins in pristane induced arthritis. Eur J Immunol 1990; 20: 2479–2484
- Res P CM, Schaar C G, Breedveld F C, van Eden W, van Embden J DA, Cohen I R, de Vries R RP. Synovial fluid T cell reactivity against 65 kD heat shock protein of mycobacteria in early chronic arthritis. Lancet 1988; ii: 478–480
- Tsoulfa G, Rook G AW, Bahr G, Sattar M A, Young D B, Mehlert A, van Embden J DA, Hay F, Isenberg D, Lydyard P ML. Elevated IgG antibody levels to the mycobacterial 65 kDa heat shock protein are a characteristic of patients with rheumatoid arthritis. Scand J Immunol 1989; 30: 519–527
- Thompson S J, Hitsumoto Y, Ghoraishian M, van der Zee R, Elson C J. Cellular and humoral reactivity pattern to the mycobacterial heat shock protein hsp65 in pristane induced arthritis susceptible and hsp65 protected DBA/1 mice. Autoimmunity 1991, in press
- Parekh R B, Dwek R A, Sutton B J, Fernandes D L, Leung A, Stanworth D R, Rademacher T W, Mizuochi T, Matsuda K, Takeuchi F, Nagano Y, Miyamoto T, Kobata A. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 1985; 316: 452–57
- Rook G, Thompson S, Buckley M, Elson C, Brealey R, Lambert C, White T, Rademacher T. The role of oil and agalctosyl IgG in the induction of arthritis in rodent models. Eur J Immunol 1991; 21: 1027–1032
- Pos O, Moshage H J, Yap S H, Snieders J PM, Aarden L A, Van Gool J, Boers W, Brugman A M, Van Duk W. Effects of monocytic products, recombinant interleukin‐1, and recombinant interleukin‐6 on glycosylation of al‐acid glycoprotein: studies with primary human hepatocyte cultures and rats. Inflammation 1989; 13: 415–127
- Mackiewicz S H, Mackiewicz A. Glycoforms of acute phase proteins as diagnostic markers in rheumatic diseases. Scand J Immunol 1991, in press
- Nakao H, Nishikawa A, Nishiura T, Kanayama Y, Tarui S, Taniguchi N. Hypogalactosylation of immunoglobulin G sugar chains and elevated serum interleukin 6 in Castleman's disease. ClinicaChimicaActa 1991; 197: 221–228
- van Snick J. Interleukin‐6: an overview. Annu Rev Immunol 1990; 8: 253–789
- Hirano T, Akira S, Taga T, Kishimoto T. Biological and clinical aspects of interleukin 6. Immunol Today 1990; 11: 443–149
- Hirano T, Matsuda T, Turner M, Miyasaka N, Buchan G, Tang B, Sato B, Sato K, Shimizu M, Maini R, Feldmann M, Kishimoto T. Excessive production of interleukin 6/B cell stimulatory factor‐2 in rheumatoid arthritis. Eur J Immunol 1988; 18: 1797–1801
- Houssiau F A, Devogelaer J P, van Damme J, de Deuxchaisnes C N, van Snick J. Interleukin‐6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum 1988; 31: 784–788
- Lotz M, Jirik F, Kabouridis P, Tsoukas C, Hirano T, Kishimoto T, Carson D A. B cell stimulation factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes. J Exp Med 1988; 167: 1253–1258
- Uyttenhove C, Coulif P G, van Snick J. T cell growth and differentiation induced by interleukin‐HPl/IL‐6, the murine hybridoma/plasmacytoma growth factor. J Exp Med 1988; 167: 1417–1427
- Tosato G, Pike S. Interferon‐β2/interleukin‐6 is a co‐stimulant for human T lymphocytes. J Immunol 1988; 141: 1556–1562
- Takai Y, Seki N, Senoh H, Yokota T, Lee F, Hamaoka T, Fujiwara H. Enhanced production of interleukin‐6 in mice with type II collagen‐induced arthritis. Arthritis Rheum 1989; 32: 594–600
- Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Meth 1983; 65: 55–63
- Matsuda T, Hirano T, Nagasawa S, Kishimoto T. Identification of a2‐macroglobulin as a carrier protein for IL‐6. J Immunol 1989; 142: 148–152
- Mihara M, Ikuto M, Koishihara Y, Oshugi Y. Interleukin 6 inhibits delayed‐type hypersensitivity and the development of adjuvant arthritis. Eur J Immunol 1991; 21: 2327–2331